Protocol Title: Phase II Trial of High Dose Lenalidomide in Patients With MDS and AML With Trilineage Dysplasia (AML-TLD).
Phase of Trial: Phase II
Latest Information Update: 24 May 2018
At a glance
- Drugs Lenalidomide (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 08 Dec 2015 Results (n=27), presented at the 57th Annual Meeting and Exposition of the American Society of Hematology.
- 28 Mar 2009 New trial record